Literature DB >> 26722054

A Five-year Survey of Cancer Prevalence in Sudan.

Mohamed E M Saeed1, Jingming Cao1, Babikir Fadul2, Onat Kadioglu1, Hassan E Khalid3, Zahir Yassin4, Siddig M Mustafa2, Elfatih Saeed5, Thomas Efferth6.   

Abstract

BACKGROUND: While cancer epidemiology is well-investigated in developed countries, the cancer burden in Africa is less well documented. We provide cancer statistics of 33,201 patients from all Sudan diagnosed at the Radiation and Isotope Centre in Khartoum (RICK). This hospital covers approximately 80% of patients with cancer in Sudan and is, therefore, considered representative for the situation in this country.
MATERIALS AND METHODS: Data from 2009-2013 were collected at RICK. Cancer diagnoses were made by standard pathological and radiological methods. Epidemiological data were categorized by age, gender, resident state, marital status etc. and subjected to statistical analyses by SPSS 21v.
RESULTS: The cancer prevalence rate per year was 5,000-7,000 among adults and 300-400 among children, with increasing tendency for adults. Male:female ratios were 1:1.18 for adults and 1.46:1 for children. The five most frequent tumour types were breast cancer, leukaemia, prostatic carcinoma, lymphoma and colorectal carcinoma in adults and leukaemia, lymphoma, eye tumours, sarcoma and brain tumours in children. Remarkably, the median age of cancer diagnosis was 10-20 years higher in men than in women, mainly due to earlier onset of gender-related tumours in females (cancer of breast, cervix, or ovary) than in men (prostatic carcinoma). Chronic myeloid leukaemia was the most frequent haematopoietic malignancy in adults and acute lymphoblastic leukaemia in children. Comparing cancer cases with population numbers of Sudanese states, Northern Sudan, River Nile and Khartoum revealed up to 8-fold higher cancer incidence rates than Al Gedarif, Southern Dafur and Blue Nile. The other states had intermediate incidence rates. Interestingly, oesophageal carcinoma occurred proportionally more frequently in Kassala (rank 3) than in the entire Sudan (rank 7) or other states.
CONCLUSION: This is the largest survey on cancer burden in Sudan. It may serve as basis for governmental programmes for assessing risk factors, improving cancer prevention (e.g. by educational and vaccination programmes) and cancer therapy in the future. Copyright
© 2016 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.

Entities:  

Keywords:  Cancer statistics; Sub-Saharan Africa; epidemiology; neoplasms; risk factors

Mesh:

Year:  2016        PMID: 26722054

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  9 in total

1.  Protein Expression Profiling and Virtual Drug Screening as an Approach for Individualized Therapy of Small Cell Vaginal Carcinoma.

Authors:  Mohamed E M Saeed; Hassan E Khalid; Sailesh K Thakur; Thomas Efferth
Journal:  Cancer Genomics Proteomics       Date:  2022 Jul-Aug       Impact factor: 3.395

Review 2.  Mapping Evidence on the Burden of Breast, Cervical, and Prostate Cancers in Sub-Saharan Africa: A Scoping Review.

Authors:  Alfred Musekiwa; Maureen Moyo; Mohanad Mohammed; Zvifadzo Matsena-Zingoni; Halima Sumayya Twabi; Jesca Mercy Batidzirai; Geoffrey Chiyuzga Singini; Kabelo Kgarosi; Nobuhle Mchunu; Portia Nevhungoni; Patricia Silinda; Theodora Ekwomadu; Innocent Maposa
Journal:  Front Public Health       Date:  2022-06-16

3.  Early molecular response in East African Philadelphia chromosome-positive chronic myeloid leukaemia patients treated with Imatinib and barriers to access treatment.

Authors:  Oliver Henke; Priscus John Mapendo; Elifuraha Wilson Mkwizu; Philipp le Coutre
Journal:  Ecancermedicalscience       Date:  2020-08-18

4.  Immunohistochemical expression of Cyclin D1 among Sudanese patients diagnosed with benign and malignant prostatic lesions.

Authors:  Eiman Siddig Ahmed; Lubna S Elnour; Rowa Hassan; Emmanuel E Siddig; Mintu Elsa Chacko; Eman T Ali; Mona A Mohamed; Abdalla Munir; Mohamed S Muneer; Nouh S Mohamed; Ali M M Edris
Journal:  BMC Res Notes       Date:  2020-06-17

5.  Premenopausal Breast Cancer Risk Factors and Associations with Molecular Subtypes: A Case-Control Study.

Authors:  Faustin Ntirenganya; Jean Damascene Twagirumukiza; Georges Bucyibaruta; Belson Rugwizangoga; Stephen Rulisa
Journal:  Int J Breast Cancer       Date:  2021-10-08

6.  Epidemiology of ovarian cancers in Zaria, Northern Nigeria: a 10-year study.

Authors:  Marliyya Sanusi Zayyan; Saad Aliyu Ahmed; Adekunle O Oguntayo; Abimbola O Kolawole; Tajudeen Ayodeji Olasinde
Journal:  Int J Womens Health       Date:  2017-11-22

7.  Spatial distribution of breast cancer in Sudan 2010-2016.

Authors:  Marwa Maweya Abdelbagi Elbasheer; Ayah Galal Abdelrahman Alkhidir; Siham Mohammed Awad Mohammed; Areej Abuelgasim Hassan Abbas; Aisha Osman Mohamed; Isra Mahgoub Bereir; Hiba Reyad Abdalazeez; Mounkaila Noma
Journal:  PLoS One       Date:  2019-09-16       Impact factor: 3.240

8.  Immunohistochemical expression of PAX-8 in Sudanese patients diagnosed with malignant female reproductive tract tumors.

Authors:  Eman T Ali; Nouh S Mohamed; Irene R Shafig; Mohamed S Muneer; Abubaker Ahmed Yosif; Lamis Ahmed Hassan; Areeg M Mohamed; Ayman Ahmed; Emmanuel E Siddig
Journal:  BMC Res Notes       Date:  2020-08-26

Review 9.  In transition: current health challenges and priorities in Sudan.

Authors:  Esmita Charani; Aubrey J Cunnington; AlaEldin H A Yousif; Mohammed Seed Ahmed; Ammar E M Ahmed; Souad Babiker; Shahinaz Badri; Wouter Buytaert; Michael A Crawford; Mustafa I Elbashir; Kamal Elhag; Kamal E Elsiddig; Nadey Hakim; Mark R Johnson; Alexander D Miras; Mohamed O Swar; Michael R Templeton; Simon David Taylor-Robinson
Journal:  BMJ Glob Health       Date:  2019-08-21
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.